| # | Drug | Count |
|---|---|---|
| 0 | ETOPOSIDE | 32 |
| 1 | METHOTREXATE SODIUM | 30 |
| 2 | METHOTREXATE | 27 |
| 3 | CISPLATIN | 18 |
| 4 | CYCLOPHOSPHAMIDE | 18 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 18 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 18 |
| 7 | BLEOMYCIN SULFATE | 11 |
| 8 | DACTINOMYCIN | 8 |
| 9 | BLEOMYCIN | 7 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FLOXURIDINE | 1 | 0.0058 |
| 1 | DACTINOMYCIN | 8 | 0.0036 |
| 2 | PLATINUM | 1 | 0.0019 |
| 3 | DINOPROSTONE | 1 | 0.0012 |
| 4 | BLEOMYCIN SULFATE | 11 | 0.0011 |
| 5 | VINBLASTINE SULFATE | 2 | 0.0010 |
| 6 | 1168 BURN SPRAY | 2 | 0.0007 |
| 7 | PROCARBAZINE HYDROCHLORIDE | 3 | 0.0006 |
| 8 | ALLANTOIN | 2 | 0.0006 |
| 9 | ERTAPENEM SODIUM | 4 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 32 |
| 1 | Folate Analog Metabolic Inhibitor [EPC] | 27 |
| 2 | Alkylating Drug [EPC] | 24 |
| 3 | Platinum-based Drug [EPC] | 22 |
| 4 | Corticosteroid [EPC] | 10 |
| 5 | Actinomycin [EPC] | 8 |
| 6 | Microtubule Inhibitor [EPC] | 6 |
| 7 | Leukocyte Growth Factor [EPC] | 5 |
| 8 | Nitroimidazole Antimicrobial [EPC] | 4 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 4 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Actinomycin [EPC] | 8 | 0.0036 |
| 1 | Topoisomerase Inhibitor [EPC] | 32 | 0.0004 |
| 2 | Oxytocic [EPC] | 1 | 0.0003 |
| 3 | Alkylating Drug [EPC] | 24 | 0.0001 |
| 4 | Platinum-based Drug [EPC] | 22 | 0.0001 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 27 | 0.0001 |
| 6 | Nitroimidazole Antimicrobial [EPC] | 4 | 0.0001 |
| 7 | Carbonic Anhydrase Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 6 | 0.0000 |
| 9 | Leukocyte Growth Factor [EPC] | 5 | 0.0000 |